"It ain't over 'til it's over"a-The search for treatments and cures for Alzheimer's disease

14Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the neuroscience landscape, there is no condition with higher unmet medical and societal need than Alzheimer's disease (AD). There are significant opportunities to improve upon symptomatic treatments in AD, and as yet, there are no treatments to modify (slow, stop, or prevent) underlying disease progression. Our goals are to discover new symptomatic AD therapies with improved efficacy and longevity; to complete definitive studies that refute or prove the amyloid hypothesis, potentially opening multiple avenues to new therapeutic modalities; and to initiate tests of novel mechanisms that can prevent tau pathology and neurodegeneration. It's a critical time in the testing of novel AD therapeutics-let's hope we succeed. © 2012 American Chemical Society.

Cite

CITATION STYLE

APA

Hargreaves, R. J. (2012, November 8). “It ain’t over 'til it’s over”a-The search for treatments and cures for Alzheimer’s disease. ACS Medicinal Chemistry Letters. https://doi.org/10.1021/ml300359g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free